E Market Briefing For Wednesday, Apr. 28

Tactical behavior requires no change whatsoever. Just recognize that signs of an impending 'big-cap' correction are rising, with less erosion probably in a slew of small-cap stocks that have already consolidated or been dormant.

Tonight won't be one of my longer reports when I'm feeling better (a member deduced that), but a shorter one despite feeling alright (considering). Reason: there's nothing happening that hasn't been in-line with expectations.

That includes the heart of the FANG-type earnings reports, and most were up there in terms of results, with several encountering good news profit-taking. In such cases the key short-term is not the knee-jerk selling, but how significant the ensuing support for such stocks is. That we'll see in a day or two.

As you know most today made numbers. Google was superb (recently we've observed higher prices likely) (GOOGL), Apple is pending but should be fine (AAPL), then there is Microsoft (super results and profit-taking) (MSFT), while AMD is talking about 50% higher revenues for the year (and it's acting just as good as suspected likely) (AMD). Amgen actually missed on earnings, exceeded on revenue, and slid a bit. If any of these stocks was most impressive, it was our AMD (cost 17 or so and picked-up as a future buy when I met their developers in Berlin in 2018) (AMGN).

That IFA 'tech show' apparently will be 'live' again this year, though I doubt I'll be in shape to risk a trip abroad (which will be permitted most likely by then). Oh we did get Texas Instruments a little disappointing, is dipping but will recover. It's already nearly doubled during our coverage time over the past year plus. Nevertheless not concerned about TXN unless the market tanks (TXN).

By the way I reiterate disapproval (by me) of Prolia, Amgen's widely promoted solution for osteoporosis. I reiterate as in stock chatter while hospitalized (you didn't think doctors mostly talk about medical issues... just teasing), there was some acknowledgement of what I contended a long time ago: it causes more fractures in post-menopausal women, because new and old cells appear more dense in a scan, and yet fragility is actually increased. Just my view.

1 2
View single page >> |
How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.